# Pyxis Oncology, Inc.: Form SCHEDULE 13D/A, filed Apr 2, 2025

- Company: [Pyxis Oncology, Inc.](/companies/pyxs.md) (CIK 1782223)
- Form: SCHEDULE 13D/A
- Filed: 2025-04-02
- Accepted by EDGAR: Apr 2, 2025, 21:25 ET
- Period: not reported
- Accession: 0000950170-25-049860
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1782223/000095017025049860/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1782223/000095017025049860/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1782223/000095017025049860/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Apr 2, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-049860. Last ingested by Listed: Nov 3, 2026, 10:04 ET. No prices; not investment advice.